MeSH tree: D03.633.100.473.914.700
Once sidelined in the 1970s, psychedelic substances—ranging from esketamine (a ketamine derivative) and psilocybin (the active ingredient in hallucinogenic mushrooms) to MDMA—are being reintroduced as potential therapies ...
Dec 28, 2024
0
30
Psychedelic-assisted psychotherapy is gaining attention as a promising approach to treat patients with mental disorders for whom conventional treatments have been insufficient. A new collaborative study by researchers at ...
Dec 10, 2024
0
30
Psilocybin-assisted psychotherapy resulted in significant reductions in depression among clinicians who provided front-line COVID-19 care in 2020 and 2021. These reductions were measurably greater than those experienced by ...
Dec 5, 2024
0
48
A bipartisan panel of Georgia lawmakers on Wednesday endorsed a plan recommending the state spend up to $5 million studying the effects of ecstasy, psychedelic mushrooms and other mind-altering drugs on mental health treatments ...
Nov 21, 2024
0
33
Joe McKay tried everything medicine had to offer for the blinding headaches that began in the months after 9/11, when the former New York City firefighter spent weeks wading through the curtains of dust and smoke at the World ...
Nov 13, 2024
0
60
Acupuncture. Ketamine infusions. "Electroshock" or electroconvulsive therapy. The existing treatment options for those diagnosed with major depressive disorder (MDD) and treatment-resistant depression (TRD), may sometimes ...
Nov 12, 2024
0
23
In an exploration of psychedelic medicine's potential for treating one of psychiatry's most challenging conditions, researchers at University of California, San Diego (UCSD) have provided an analysis and further details of ...
Nov 7, 2024
0
14
Most U.S. military veterans who have used psychedelics reported in a recent study that they pursued the substances for healing or spiritual exploration, and over 80% said they benefited from the experience—even those who ...
Nov 6, 2024
0
19
A study, published in Molecular Psychiatry, led by Prof. Bernard Lerer from the Department of Psychiatry at the Hadassah—Hebrew University Medical Center shows promising results for using psilocybin, a psychedelic compound, ...
Oct 29, 2024
0
79
Monash University researchers have made a breakthrough in the study of psychedelics to treat disorders including major depression, demonstrating that rats given psilocybin exhibit increased optimism over time.
Oct 8, 2024
0
83
